Inactive Instrument
Company Constellation Pharmaceuticals, Inc.
Stocks
CNST
US2103731061
Biotechnology & Medical Research
Business description: Constellation Pharmaceuticals, Inc.
Number of employees: 154
Sales by Activity: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Executive Committee: Constellation Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | - |
Kia Khalaghpour
IRC | Investor Relations Contact | - | - |
Irina Apostolou
PRN | Corporate Officer/Principal | - | 01/08/2016 |
Brenda J. Sousa
COO | Chief Operating Officer | 62 | 01/04/2017 |
Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 15/07/2021 | |
John McKenna
BRD | Director/Board Member | - | - |
Company details: Constellation Pharmaceuticals, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.30% | +1.19% | +54.62% | +104.15% | 7.19TCr | |
| +1.25% | -3.01% | +40.12% | +77.12% | 5.94TCr | |
| +2.12% | +5.79% | +32.63% | +24.27% | 2.72TCr | |
| -3.65% | -2.42% | -13.64% | +354.19% | 2.65TCr | |
| +0.41% | +3.26% | +1.13% | -3.81% | 2.49TCr | |
| +0.40% | +0.75% | +22.91% | -9.68% | 2.06TCr | |
| -1.70% | -3.35% | +146.86% | +325.69% | 1.5TCr | |
| +0.21% | +1.21% | -6.26% | +493.02% | 1.42TCr | |
| +0.28% | -0.48% | +50.12% | +166.06% | 1.44TCr | |
| Average | -0.44% | -0.12% | +36.50% | +170.11% | 3.05TCr | |
| Weighted average by Cap. | -0.74% | -0.24% | +37.11% | +131.75% |
